Period to Accept Petitions/Oppositions Relative to the Recertification of Contraceptive Products Ended Last 31 August 2017
On 21 August 2017, FDA issued Advisory No. 2017-253 to formally begin the recertification process.
FDA Advisory No. 2017-253 opened to the public the details of the contraceptive products subject to recertification and provided the mechanics for submitting petitions and corresponding evidence on their abortifacient or non-abortifacient properties.
Also provided in FDA Advisory No. 2017-253 is the deadline for their submission which is ten (10) calendar days from the date of posting and publication. Said Adivsory was posted at the FDA’s website, www.fda.gov.ph, on 21 August 2017 and published in 2 newspapers of general circulation, namely, The Philippine Star and the Manila Times, on 21 August 2017.
August 31 marks the tenth day of the posting and publication of FDA Advisory No. 2017-253.
FDA hereby formally concludes the submission period and will proceed with the review phase of the recertification process taking due consideration of the petitions submitted and their supporting evidence.